PMA device
Model 3058 Interstim 2 Neurostimulator
Medtronic Neuromodulation · Stimulator, Electrical, Implantable, For Incontinence (EZW, Class III) · First FDA decision Jun 9, 2011, newest Jun 9, 2011Fecal incontinence and constipationOveractive bladder and urinary incontinence
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "3058 Interstim 2"
MAUDE reports
0
Brand "3058 Interstim 2", since 2015
PubMed studies
0
Mentioning "3058 Interstim 2"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Model 3058 Interstim 2 Neurostimulator
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- MODEL 3058 INTERSTIM 2 NEUROSTIMULATORPMA supplement
P970004-S087 · Decided Jun 9, 2011 · 289 days after receipt · Normal 180 Day Track
Device type: Stimulator, electrical, implantable, for incontinence (EZW) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Non-Implantable Pelvic Floor Electrical StimulatorNational determinationOn the books230.8Updated Aug 17, 2023
- Pelvic Floor Electrical Stimulation for Urinary IncontinenceNational analysisReview closedCAG-00021NUpdated Sep 15, 2026
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "3058 Interstim 2", any status and sponsor, newest update first.
- SNM vs. HBOT for Refractory IC/BPSCompleted
Shiyan City Renmin HospitalGovernment (non-federal)
NCT07091266 · 88 participants · Start Feb 1, 2021 · Primary completion Dec 31, 2022
Device: Sacral Neuromodulation (SNM) · For: Interstitial Cystitis/Bladder Pain Syndrome; Underactive Bladder
Sites: Shiyan, China
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "3058 Interstim 2", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code EZW
68,097 reports: 34,391 malfunction, 33,649 injury, 34 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0372-2025 · Started Sep 18, 2024 · Posted by FDA Nov 13, 2024
Reason given: The Wireless Rechargers in the kits may be unable to enter a recharging session upon first use.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Z-0998-2022 · Started Feb 28, 2022 · Posted by FDA Apr 22, 2022
Reason given: There is a software anomaly with the InterStim X Clinician software application with results in the data entered in the Patient Information fields not e retained and a " Data Lost" notification being displayed.
Cause as FDA categorized it: Software Design Change · Device type: Stimulator, Electrical, Implantable, For Incontinence (EZW)
Z-1147-2015 · Started Jan 9, 2015 · Posted by FDA Jun 26, 2015
Reason given: Current labeling indicates that cycling improves device longevity in every programming scenario. However, enabling cycling at certain parameter settings may decrease the device battery longevity. With cycling enabled, longevity estimate displayed on the Model 8840Programmer may be inaccurate.
Cause as FDA categorized it: Other · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
2 more recall records with a free account
Published research
The most relevant PubMed records for "3058 Interstim 2"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code EZW.
- InterStim Therapy System, Verify Evaluation SystemMedtronic Neuromodulation · PMA 2025
- Axonics Sacral Neuromodulation SystemBoston Scientific Corporation · PMA 2026
- InterStim® Sacral Nerve Stimulation Therapy System (Urinary Control )Medtronic Neuromodulation · PMA 2018
- Neuspera Sacral Neuromodulation (SNM) SystemNeuspera Medical, Inc. · PMA 2026
- Master InterStim® Therapy System, Verify® Evaluation SystemMedtronic Neuromodulation · PMA 2022
- Interstim SystemMedtronic Neuromodulation · PMA 2011
- Medtronic Interstim Tined Lead Models 3889 & 3093Medtronic Neuromodulation · PMA 2007
- Virtis Sacral Neuromodulation SystemCirtec Medical Corporation · PMA 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.